You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dose-dense anthracycline/cyclophosphamide

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Early-stage Breast Cancer Trial in Ottawa (Granulocyte Colony-Stimulating Factor (G-CSF), Omission of Granulocyte

Not yet recruiting
  • Early-stage Breast Cancer
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • Omission of Granulocyte Colony-Stimulating Factor (G-CSF)
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Cancer Centre
Feb 22, 2023

Localized Breast Cancer Trial in Dijon (Dense dose epirubicin-cyclophosphamide chemo and G-CSF (filgrastim, lenograstim), Dense

Not yet recruiting
  • Localized Breast Cancer
  • Dense dose epirubicin-cyclophosphamide chemotherapy and G-CSF (filgrastim, lenograstim)
  • Dense dose epirubicin-cyclophosphamide chemotherapy with administration of peg-G-CSF (pegfilgrastim)
  • Dijon, Bourgogne, France
    Centre Georges François Leclerc (CGFL)
Mar 24, 2022

Early Stage Breast Cancer Trial in United States (Paclitaxel, Neulasta)

Completed
Has Results
  • Early Stage Breast Cancer
  • Boston, Massachusetts
  • +3 more
Apr 11, 2022

Triple Negative Breast Cancer Trial in Worldwide (Atezolizumab, Paclitaxel, Dose-dense Doxorubicin or dose-dense Epirubicin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Concord, California
  • +429 more
Dec 12, 2022

HER2-negative Breast Cancer, Neoadjuvant Chemo Trial in Hangzhou (Epirubicin, Cyclophosphamid, Docetaxel)

Recruiting
  • HER2-negative Breast Cancer
  • Neoadjuvant Chemotherapy
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 9, 2021

Breast Cancer, Triple Negative Breast Cancer, Luminal B Trial in Belgium (Paclitaxel, Epirubicin, Cyclophosphamide)

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Charleroi, Hainaut, Belgium
  • +3 more
Aug 2, 2022

Locally Advanced Breast Cancer Trial in New York (Docetaxel, Carboplatin, Trastuzumab)

Terminated
  • Locally Advanced Breast Cancer
  • New York, New York
  • +2 more
Oct 18, 2021

HER2-negative Breast Cancer, Advanced Solid Tumor Trial in Singapore (ADG106, Doxorubicin, Cyclophosphamide)

Recruiting
  • HER2-negative Breast Cancer
  • Advanced Solid Tumor
  • Singapore, Singapore
    National University Hospital
Jun 9, 2022

Breast Cancer Trial in Boston, Hooksett (Doxorubicin, Cyclophosphamide, Paclitaxel)

Completed
Has Results
  • Breast Cancer
  • Boston, Massachusetts
  • +3 more
Apr 26, 2021

Triple Negative Breast Cancer, Breast Cancer Trial in United States (Trilaciclib, Cylophosphamide, Doxorubicin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
  • Los Alamitos, California
  • +6 more
Jan 25, 2023

Colorectal Cancer Metastatic, Colorectal Cancer Stage IV, TP53 Gene Mutation Trial in Bergen (Cyclophosphamide)

Terminated
  • Colorectal Cancer Metastatic
  • +2 more
  • Bergen, Norway
    Haukeland University Hospital
Jan 20, 2021

Breast Cancer, Triple Negative Breast Cancer Trial in United States (Carboplatin, Paclitaxel, Doxorubicin)

Active, not recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Rockford, Illinois
  • +5 more
Mar 29, 2021

Stage III Breast Cancer AJCC V7 Trial in Bergen (epirubicin/docetaxel sequential)

Active, not recruiting
  • Stage III Breast Cancer AJCC V7
  • epirubicin/docetaxel sequential
  • Bergen, Norway
    Dept of Oncology
Jun 24, 2022

Breast Cancer Trial in Frankfurt (Epirubicin, nab-Paclitaxel, Cyclophosphamide)

Completed
  • Breast Cancer
  • Frankfurt, Hessen, Germany
    Klinikum Frankfurt Höchst
Feb 1, 2021

Diffuse Large Cell Lymphoma, Burkitt's Lymphoma, High Grade B-cell Lymphoma Trial in United States (Rituximab, IT Cytarabine)

Completed
  • Diffuse Large Cell Lymphoma
  • +2 more
  • Buffalo, New York
  • +4 more
Oct 29, 2021

BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Trial in Barretos (Doxorubicin, Carboplatin, Paclitaxel)

Completed
  • BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
  • Barretos, SP, Brazil
    Barretos Cancer Hospital
Dec 25, 2022

Tissue Samples From Women Who Underwent Chemotherapy for Lymph

Completed
  • Breast Cancer
  • Saint Louis, Missouri
    Washington University
Aug 16, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial

Not yet recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +4 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Jun 26, 2023

Cardiotoxicity of Anthracyclines in Diffuse Large B-Cell

Active, not recruiting
  • Lymphoma
  • +2 more
  • R-CHOP with doxorubicin
  • Messina, ME, Italy
  • +17 more
Apr 22, 2022

Large B-cell Lymphoma Trial in Houston (Prednisone, Rituximab, Cyclophosphamide)

Not yet recruiting
  • Large B-cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 19, 2023

Triple-negative Breast Cancer Trial in Milano (Fasting-mimicking diet, Metformin, Preoperative chemo)

Active, not recruiting
  • Triple-negative Breast Cancer
  • Fasting-mimicking diet
  • +2 more
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Jan 17, 2023

HER-2 Positive Breast Cancer Trial in Tianjin (TCbHP VS ddEC-THP)

Recruiting
  • HER-2 Positive Breast Cancer
  • TCbHP VS ddEC-THP
  • Tianjin, Tianjin, China
    Breast Oncology, Tianjin Medical University Cancer Institute and
May 15, 2023

CINV Trial in Odense (Ondansetron, Placebo, Dexamethasone)

Completed
Has Results
  • CINV
  • Odense, Denmark
    Odense University Hospital
Nov 11, 2020

Breast Cancer Trial in Amsterdam (Intensified Cyclophophamide, Carboplatin and Thiotepa, dose dense adriamycine and

Terminated
  • Breast Cancer
  • Intensified Cyclophophamide, Carboplatin and Thiotepa
  • dose dense adriamycine and cyclophosphamide
  • Amsterdam, Netherlands
    NKI-AVL
Jan 20, 2021

Breast Cancer Trial in Worldwide (5-Fluorouracil, Cyclophosphamide, Docetaxel)

Completed
Has Results
  • Breast Cancer
  • Mobile, Alabama
  • +79 more
Aug 18, 2021